Evaluation of pediatric CNS malignancies with 99mTc-methoxyisobutylisonitrile SPECT

Journal of Nuclear Medicine

Volumn 43, Issue 11, 2002, Pages 1438-1443

  Kirton, Adam ^a   Kloiber, Reinhard ^a   Rigel, Jane ^a   Wolff, Johannes ^a  

^a ALBERTA CHILDREN'S HOSPITAL   (Canada)

Author keywords

Brain tumor; Child; Sestamibi; SPECT

Indexed keywords

METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; TRACER;

ADOLESCENT; ARTICLE; ASTROCYTOMA; BRAIN CANCER; CHILD; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; CRANIOPHARYNGIOMA; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EVALUATION; FEMALE; GLIOBLASTOMA; GLIOMA; HUMAN; MALE; MEDULLOBLASTOMA; NUCLEAR MAGNETIC RESONANCE IMAGING; OPTIC NERVE GLIOMA; PILOT STUDY; PRIORITY JOURNAL; SCINTILLATION CAMERA; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADOLESCENT; BRAIN NEOPLASMS; BRAIN STEM NEOPLASMS; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GLIOMA; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; PILOT PROJECTS; RADIOPHARMACEUTICALS; SPINAL NEOPLASMS; TECHNETIUM TC 99M SESTAMIBI; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036840158     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Oriuchi N, Tamura M, Shibazaki T, Ohye C, Watanabe N. Clinical evaluation of thallium-201 SPECT in supratentorial gliomas: Relationship to histological grade, prognosis, and proliferative activities. J Nucl Med. 1993;34:2089-2090.
2. O'Tuama LA, Treves ST, Larar JN. Thallium-201 versus technetium-99m-MIBI SPECT in evaluation of childhood brain tumors: A within subject comparison. J Nucl Med, 1993;34:1045-1051.
3. Bahargava S, Coel M, Wilkinson R. Thallium-201 single photon emission computed tomography imaging in a pediatric brain tumor: A case report. Pediatr Neurosurg. 1991;17:95-97.
4. Carvalho PA, Schwartz RB, Alexander E. Extracranial metastatic glioblastoma: Appearance on thallium-201-chloride/technetium-99m-HMPAO SPECT images. J Nucl Med. 1991;32:322-324.
5. Kaplan WD, Takvorian T, Morris JH, et al. Thallium-201 brain tumor imaging: A comparative study with pathologic correlation. J Nucl Med. 1987;28:47-57.
6. Black RL, Hawkis RA, Kim KT. Use of thallium-201 SPECT to quantitate malignancy grade of gliomas. J Neurosurg. 1989;71:342-346.
7. Kim KT, Black KT, Marciano D. Thallium-201 SPECT imaging of brain tumors: Methods and results. J Nucl Med. 1990;31:965-969.
8. 99mTc-HMPAO. AJNR. 1992;12:1187-1192.
9. 99mTc-HMPAO SPECT imaging of treated childhood brain tumors. Pediatr Neurol. 1991;7:249-257.
10. Rollins N, Lowry P, Shapiro K. Comparison of gadolinium enhanced MR and thallium-201 single photon emission computed tomography in pediatric brain tumors. Pediatr Neurosurg. 1995;22:8-14.
11. Bagni B, Pinna L, Tamarozzi R, et al. SPET imaging of intracmnial tumours with 99Tcm-sestamibi. Nucl Med Commun. 1995;16:258-264.
12. Aktolun C, Bayhan H, Kir M. Clinical experience with Tc-99m MIBI imaging in patients with malignant tumors: Preliminary results and comparison with TI-201. Clin Nucl Med. 1992;17:171-176.
13. Park CH, Sataloff R, Richard M, Zhang M, Kim SM. Tc-99m MIBI brain SPECT of cerebellopontine angle tumors. Clin Nucl Med. 1996;21:375-378.
14. Wolff JEA, Myles T, Egeler M, Pinto A, Kloiber, T. Sestamibi detection of choroid plexus carcinoma. Med Pediatr Oncol. 2000;25:401-409.
15. Balon HR, Fink-Bennet TD, Stoffer SS. Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid. J Nucl Med. 1992;33:1393-1395.
16. 99mTc-sestamibi SPET? Eur J Nucl Med. 1998;25:401-409.
17. Maublant JC, Zhang Z, Rapp M, Oilier M, Michelot J, Veyre A. In vitro uptake of technetium-99m-tehoroxime in carcinoma cell lines and normal cells: Comparison with technetium-99m-sestamibi and thallium-201. J Nucl Med. 1993:34: 1949-1952.
18. Briele B, Hotze A, Kropp J, et al. Comparison of 201-thallium and 99m-Tc-MIBI in the follow-up of undifferentiated thyroid carcinoma. Nuklearmedizin. 1991; 30:115-124.
19. Caner B, Kitapci M, Aras T, et al. Increased accumulation of hexakis (2-methoxyisobutylisonitrile) technetium in osteosarcoma and its metastatic lymph nodes. J Nucl Med. 1991:32:1977-1978.
20. Baillet G, Albequerque L, Chen Q, Poisson M, Delattre JY. Evaluation of single photon emission tomography imaging of supratentorial brain gliomas with technetium-99m-sestamibi. Eur J Nucl Med. 1994;21:1061-1066.
21. Park CH, Kim SM, Zhang JJ, Intenzo CM, McEwan JR. Tc-99m MIBI brain SPECT in the diagnosis of recurrent glioma. Clin Nucl Med. 1994;19:57-58.
22. Shih WJ, Lee JK, Milan P. Discordant technetium-99m-MIBI and technetium-99m-HMPAO uptake of recurrent occipital meningioma on brain SPECT images. J Nucl Med. 1996;37:1183-1185.
23. Mira ML, Popa N, Huysmans E, Lenaers A, Schoutens A. Tc-99m sestamibi SPECT imaging of a brain metastasis in a man with lung tumor and increased sexual activity. Clin Nucl Med. 1996;21:745-746.
24. Maffioli, L, Gasparini M, Chiti A, et al. Clinical role of technetium-99m sestamibi single photon emission tomography in evaluating pretreated patients with brain tumors. Eur J Nucl Med. 1996;23:308-311.
25. O'Tuama LA, Packard AB, Treves ST. SPECT imaging of pediatric brain tumors with hexakis (methoxyisobutylisonitrile) technetium. J Nucl Med. 1990; 31:2040-2041.
26. Arbab AS, Koizumi K, Toyama K, Araki T. Uptake of technetium-99m-tetrofosmin, technetium-99m-sestamibi, and thallium-201 in tumor cell lines. J Nucl Med. 1996;37:1551-1556.
27. Tomura N, Hirano H, Watanabe O, et al. Preliminary results with technedum-99m MIBI SPECT imaging in patients with brain tumors: Correlation with histological and neuroradiological diagnoses and therapeutic response. Comput Med Imaging Graph. 1997;21:293-298.
28. Luker GD, Fracasso PM, Dobkin J, Piwnica-Worms D. Modulation of the multidrug resistance P-glycoprotein: Detection with technetium-99m-sestamibi in vivo. J Nucl Med. 1997;38:369-372.
29. Mountz JM, Raymond PA, McKeever PE. Specific localization of thallium-201 in human high-grade astrocytoma by microautoradiography. Cancer Res. 1989; 49:4053-4057.
30. Crane P, Laliberte R, Heminway S. Effect of mitochondrial viability and metabolism of technetium-99m-sestamibi. Eur J Nucl Med. 1993;20:20-25.
31. Delmon-Moingeon LI, Piwnica-Worms D, van den Abbeele, et al. Uptake of the cation hexakis (2-metboxyisobutylisonitrile)-technetium-99m by human carcinoma cell lines in vitro. Cancer Res. 1990;50:2198-2202.
32. O'Tuama LA, Poussaint TY, Anthony DC, Treves ST. Childhood brain tumor: Neuroimaging correlated with disease outcome. Pediatr Neurol. 1998;19:259-262.
33. Hassan IM, Sahweil A, Constantinides C, et al. Uptake and kinetics of Tc-99m hexakis 2-methoxy isobutylisonitrile in benign and malignant lesions of the lungs. Clin Nucl Med. 1989;14:333-340.